FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 309:1434-1440 December 8, 1983 Number 23 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

New knowledge of the relationship between the varicella-zoster virus and its host suggests a heretofore unappreciated dynamic pattern. Molecular finger-printing has demonstrated a degree of heterogeneity between different strains of virus. It is probable that exogenous reinfection with different strains and endogenous reactivation are commonplace events, although usually asymptomatic. The lability of the endogenous interaction inversely parallels the responsiveness of the cell-mediated immune system--a major factor in viral containment by the human host. Thus, the therapeutic use of immunosuppressive or cytotoxic substances increases the morbidity and mortality associated with varicella-zoster. Promising new approaches to the prevention and treatment of the virus should alter the balance in favor of the host.

This article has been cited by other articles:

• Kimberlin, D. W., Whitley, R. J. (2007). Varicella-Zoster Vaccine for the Prevention of Herpes Zoster. NEJM 356: 1338-1343 [Full Text]  
• Burke, M. S. (2007). Herpes Zoster Vaccine: Clinical Trial Evidence and Implications for Medical Practice. JAOA: Journal of the American Osteopathic Association 107: S14-S18 [Abstract] [Full Text]  
• Oxman, M. N., Levin, M.J., Johnson, G.R., Schmader, K.E., Straus, S.E., Gelb, L.D., Arbeit, R.D., Simberkoff, M.S., Gershon, A.A., Davis, L.E., Weinberg, A., Boardman, K.D., Williams, H.M., Zhang, J. H., Peduzzi, P.N., Beisel, C.E., Morrison, V.A., Guatelli, J.C., Brooks, P.A., Kauffman, C.A., Pachucki, C.T., Neuzil, K.M., Betts, R.F., Wright, P.F., Griffin, M.R., Brunell, P., Soto, N.E., Marques, A.R., Keay, S.K., Goodman, R.P., Cotton, D.J., Gnann, J.W. Jr., Loutit, J., Holodniy, M., Keitel, W.A., Crawford, G.E., Yeh, S.-S., Lobo, Z., Toney, J.F., Greenberg, R.N., Keller, P.M., Harbecke, R., Hayward, A.R., Irwin, M.R., Kyriakides, T.C., Chan, C.Y., Chan, I.S.F., Wang, W.W.B., Annunziato, P.W., Silber, J.L., the Shingles Prevention Study Group, (2005). A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. NEJM 352: 2271-2284 [Abstract] [Full Text]  
• Ordonez, G., Pineda, B., Garcia-Navarrete, R., Sotelo, J. (2004). Brief Presence of Varicella-zoster Viral DNA in Mononuclear Cells During Relapses of Multiple Sclerosis. Arch Neurol 61: 529-532 [Abstract] [Full Text]  
• Lim, W S, Macfarlane, J T, Colthorpe, C L (2001). Respiratory diseases in pregnancy {bullet} 2: Pneumonia and pregnancy. Thorax 56: 398-405 [Full Text]  
• Gilden, D. H., Kleinschmidt-DeMasters, B.K., LaGuardia, J. J., Mahalingam, R., Cohrs, R. J. (2000). Neurologic Complications of the Reactivation of Varicella-Zoster Virus. NEJM 342: 635-645 [Full Text]  
• Alconada, A., Bauer, U., Baudoux, L., Piette, J., Hoflack, B. (1998). Intracellular Transport of the Glycoproteins gE and gI of the Varicella-Zoster Virus. gE ACCELERATES THE MATURATION OF gI AND DETERMINES ITS ACCUMULATION IN THE TRANS-GOLGI NETWORK. J. Biol. Chem. 273: 13430-13436 [Abstract] [Full Text]